CVS Health Corp. (NYSE:CVS), and Humana Inc. (NYSE:HUM) declined last week, but while investors focused on the Donald Trump ...

Feb 5 () - CVS Health said on Thursday it would swap out Amgen and Eli Lilly's bone disease treatments for ​lower-cost ...

Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.

Cigna Corp's Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated ...

The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and ...

Operating efficiency was another area of relative strength. Cigna’s SG&A expense ratio fell to 5.3% for full-year 2025, down ...

The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.

Penn State University has sued several pharmaceutical companies alleging they conspired to inflate the price of insulin and ...

On February 5, 2026, Cigna’s board approved an increase in the quarterly dividend to $1.56 per share of common stock, up from ...

Tuesday afternoon, the House of Representatives voted in favor of a spending bill that includes major pharmacy benefit manager (PBM) reforms aimed at increasing price transparency for consumers and ...

The CEOs of the nation’s largest health insurers drew the ire of lawmakers on both sides of the aisle during congressional hearings that went for more than nine hours Jan. 22 over industry ...